NCT06914661View on ClinicalTrials.gov

Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 25, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

October 30, 2025

Conditions
Breast Cancer MetastaticEfficacy and Safety
Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER